A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
NV
Recent Filings
- SC 13G21.2 KBActavis, Inc.Feb 12, 10:38 AM ET·0000902219-15-000044
- 8-K17.8 KBActavis, Inc.Nov 8, 5:00 PM ET·0001193125-13-435426
- 10-Q7.9 MBActavis, Inc.Oct 31, 9:17 AM ET·0001193125-13-419835
- 8-K298.2 KBActavis, Inc.Oct 29, 7:30 AM ET·0001193125-13-414339
- 8-K13.2 KBActavis, Inc.Oct 22, 5:06 PM ET·0001193125-13-406758
- 45.4 KBActavis, Inc.Oct 2, 9:26 PM ET·0001179110-13-015068
- 45.5 KBActavis, Inc.Oct 2, 9:25 PM ET·0001179110-13-015067
- 45.4 KBActavis, Inc.Oct 2, 9:23 PM ET·0001179110-13-015066
- 45.4 KBActavis, Inc.Oct 2, 9:23 PM ET·0001179110-13-015065
- 45.3 KBActavis, Inc.Oct 2, 9:21 PM ET·0001179110-13-015064
Insiders
10- AMATO LYNNEVP, Brand Sales & Operations
- Bisaro PaulDirector, President & CEO
- BODINE CHRIS WDirector
- BOYER ANDREW SSVP,Sales&Mktg,US Generics
- BRITT DONALD ASr. VP, Quality Assurance
- Brunner Patrick G.SVP,Manufacturing Operations
- BUCHEN DAVID ASr. VP, General Counsel & Sec.
- Carmichael ClareSR VP, Human Resources
- CHAO ALLENDirector, Chairman, President & CEO
- CHOW YEE MARIASr. VP, New Product Intro/Oper
Tickers
No tickers on record
Addresses
business
MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY
PARSIPPANY, NJ, 07054
mailing
MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY
PARSIPPANY, NJ, 07054
Former Names
- Actavis, Inc.2015-03-05
- WATSON PHARMACEUTICALS INC2013-01-14